| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,475 |
4,929 |
$245K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,508 |
2,302 |
$83K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,008 |
2,777 |
$72K |
| 64493 |
|
426 |
397 |
$17K |
| 64495 |
|
427 |
397 |
$10K |
| 64494 |
|
427 |
397 |
$10K |
| 99205 |
Prolong outpt/office vis |
70 |
69 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
315 |
310 |
$7K |
| 62323 |
|
94 |
82 |
$4K |
| 95911 |
|
13 |
12 |
$2K |
| 95886 |
|
13 |
12 |
$2K |
| 64490 |
|
25 |
25 |
$1K |
| 64635 |
|
12 |
12 |
$1K |
| 77003 |
|
959 |
882 |
$1K |
| 99001 |
|
214 |
208 |
$879.71 |
| 64491 |
|
26 |
26 |
$689.70 |
| 64492 |
|
26 |
26 |
$669.84 |
| 20610 |
|
36 |
31 |
$665.96 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
49 |
49 |
$540.96 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
141 |
112 |
$488.90 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
37 |
36 |
$488.82 |
| 64636 |
|
12 |
12 |
$487.30 |
| 76942 |
|
89 |
64 |
$414.05 |
| 76881 |
|
15 |
12 |
$400.75 |
| 20550 |
|
29 |
26 |
$329.06 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
698 |
611 |
$326.89 |
| 72100 |
|
19 |
19 |
$242.73 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
377 |
317 |
$190.18 |
| 72040 |
|
16 |
16 |
$173.79 |
| A4550 |
Surgical trays |
405 |
348 |
$100.00 |
| 77002 |
|
13 |
12 |
$52.89 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
58 |
45 |
$1.27 |